Please try another search
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| LUPNc1:NS | NSE | INR | Delayed | |
| LUPN | NSE | INR | Real-time | |
| LUPNc2:NS | NSE | INR | Delayed | |
| LUPNc3:NS | NSE | INR | Delayed | |
| LUPN | BSE | INR | Delayed |
Lupin Limited (500257, NSE: LUPIN) announced that results from its Phase 1a trial of LNP8701, an experimental cancer treatment, have been presented at the American Society of...
Lupin Limited (500257, NSE: LUPIN) announced it received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for Famotidine Injection USP, 20 mg/2...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Sell | BUY | Strong Buy | Strong Buy |
| Summary | Strong Buy | Neutral | Strong Buy | Strong Buy | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Completed Patterns | |||||
| Doji Star Bearish | 1W | 1 | Jul 05, 2026 | ||
| Homing Pigeon | 30 | 1 | Jul 16, 2026 17:00 | ||
| Gravestone Doji | 1W | 3 | Jun 21, 2026 | ||
| Three Inside Down | 1D | 3 | Jul 13, 2026 | ||
| Engulfing Bearish | 1D | 11 | Jul 01, 2026 | ||
| Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| NSE | 2,490.50 | 2,490.70 | 2,496.60 | 444,975 | +0.54% | INR | 17:59:50 | ||
| NSE | 2,500.50 | 2,498.00 | 2,505.00 | 626,383 | +0.30% | INR | 17:59:59 | ||
| NSE | 2,497.70 | 2,492.00 | 2,499.00 | 104,125 | +0.67% | INR | 17:59:49 | ||
| NSE | 2,501.00 | 2,497.80 | 2,509.40 | 2,125 | +0.44% | INR | 17:43:41 | ||
| BSE | 2,500.05 | 2,499.00 | 2,516.00 | 9,440 | +0.33% | INR | 17:59:59 |
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| International Container | 990.000 | 1,018.000 | 990.000 | -9.000 | -0.90% | 854.48K | 14:58:59 | ||
| Bank of the Philippine Islands | 104.20 | 105.00 | 102.70 | +0.70 | +0.68% | 2.04M | 14:58:59 | ||
| Jollibee Foods | 149.00 | 150.30 | 146.50 | +2.50 | +1.71% | 1.26M | 14:57:05 | ||
| LT Group | 14.340 | 14.620 | 14.340 | -0.160 | -1.10% | 841.30K | 14:58:59 | ||
| First Gen | 19.72 | 20.75 | 19.40 | -0.08 | -0.40% | 4.27M | 14:58:59 | ||
| Semirara Mining | 20.10 | 21.40 | 20.10 | -0.80 | -3.83% | 6.21M | 14:58:59 | ||
| PLDT | 1,238.00 | 1,238.00 | 1,188.00 | +46.00 | +3.86% | 92.51K | 14:58:59 | ||
| BDO Unibank | 126.80 | 127.00 | 124.90 | +2.80 | +2.26% | 2.47M | 14:58:59 | ||
| Apex Mining | 12.4800 | 12.5800 | 12.2200 | +0.2600 | +2.13% | 973.10K | 14:58:59 | ||
| DMCI | 7.310 | 7.370 | 7.190 | +0.110 | +1.53% | 6.94M | 14:58:59 |
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review